Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune variations in bipolar disorder: phasic differences.

Abigail Ortiz-Domínguez1, María Eugenia Hernández, Carlos Berlanga

  • 1Bipolar Disorder Clinic, National Institute of Psychiatry, Mexico City, Mexico.

Bipolar Disorders
|September 12, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The kynurenine pathway: an immunometabolic bridge linking systemic inflammation to neuroaxonal vulnerability in multiple sclerosis.

Frontiers in cellular neuroscience·2026
Same author

Deciphering the neurotoxic effects of emerging pollutants: Bisphenols and phthalates as disruptors of brain function and mental health.

iScience·2026
Same author

Identification of potential biomarkers of fibromyalgia using a proteomic approach in peripheral blood mononuclear cells.

Chronic illness·2026
Same author

Reduced peripheral serotonin levels in women with multiple sclerosis: associations with underweight status, treatment duration, and use of interferon beta 1a.

Frontiers in cellular neuroscience·2026
Same author

Neonatal Clomipramine Exposure Disrupts Epididymal Serotonin Signaling and Programs Sperm Dysfunction in Adult Rats.

International journal of molecular sciences·2026
Same author

Microglial Activation in Cerebrovascular Accidents and the Manifestation of Major Depressive Disorder: A Comprehensive Review.

Brain sciences·2026
Same journal

Enhancing Affective Cognitive Control in Bipolar Disorder Using Transcranial Alternating Current Stimulation: A Double-Blind, Randomized, Sham-Controlled Clinical Trial and Proof of Concept Study.

Bipolar disorders·2026
Same journal

Psychotropic Prescribing Patterns Among Bipolar-I Patients Prior to Established Bipolar-I Disorder Diagnosis.

Bipolar disorders·2026
Same journal

Speech and Language Markers of Bipolar Disorder: Challenges and Opportunities.

Bipolar disorders·2026
Same journal

Can We Improve the Prediction of Early Onset Mania and Hypomania in the Community?

Bipolar disorders·2026
Same journal

How Do Parents With Bipolar Disorder Perceive the Risk to the Next Generation? Results From a Qualitative Study.

Bipolar disorders·2026
Same journal

Cross-Sectional and Longitudinal Comparison of Commonly Used Screening Tools for Bipolar Disorders.

Bipolar disorders·2026
See all related articles

Bipolar disorder (BD) patients exhibit distinct serum cytokine profiles during manic and depressive phases. These immunological variations, including levels of interleukin (IL)-6, TNF-alpha, and IL-4, highlight phase-specific inflammatory differences in BD.

Area of Science:

  • Neuroscience
  • Immunology
  • Psychiatry

Background:

  • Bipolar disorder (BD) is a mood disorder with distinct manic and depressive phases.
  • Immune system dysregulation, particularly involving cytokines, is implicated in BD pathophysiology.
  • Understanding phase-specific immunological variations can offer insights into BD mechanisms.

Purpose of the Study:

  • To quantify serum levels of key cytokines, including interleukin (IL)-1beta, -2, -4, -6, and tumor necrosis factor alpha (TNF-alpha).
  • To characterize the distinct immunological profiles of patients with bipolar disorder (BD) during manic (BDm) and depressive (BDd) phases.
  • To compare these cytokine levels between BD phases and healthy controls.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was employed to measure serum cytokine concentrations.

Related Experiment Videos

  • A cohort of 20 patients with Bipolar I disorder (10 manic, 10 depressive) and 33 healthy controls were recruited.
  • Patients were assessed off psychopharmacological treatment for at least three weeks, with specific clinical rating scales used for phase diagnosis.

    • Main Results:

    • Significant differences in serum cytokine levels were observed between BD patients and controls (p < 0.05).
    • Depressive phase (BDd) showed elevated IL-6 and TNF-alpha, with decreased IL-2.
    • Manic phase (BDm) exhibited increased TNF-alpha and IL-4, alongside reduced IL-1beta and IL-2.
    • Distinct cytokine patterns were identified for mania (high IL-4, low IL-1beta/IL-6) versus depression (inverse pattern).

    Conclusions:

    • The study confirms the existence of significant phasic differences in serum cytokine levels in bipolar disorder.
    • These findings suggest distinct immunological signatures associated with manic and depressive episodes.
    • Cytokine profiling may contribute to understanding the neuroimmunological basis of BD phase transitions.